Results 81 to 90 of about 2,419 (196)
A method was developed and validated for analysis of Formoterol Fumarate and Fluticasone Propionate in dry powder inhaler formulations. Separation was achieved on a HiQ Sil C18HS, 250×4.6 mm, 5 µm column using a mobile phase consisting of Acetonitrile: 0.
Sagar, Magar M +2 more
core +1 more source
A perspective current and past modes of inhalation therapy
Abstract Inhalation is the preferred route of delivery for anti‐asthma and chronic obstructive pulmonary disease (COPD) drugs. The use of this route has demonstrated efficacy in these and other conditions, it offers rapid onset of action, and is associated with minimal systemic exposure, thereby reducing the risk of adverse effects.
José Canto Mangana +6 more
wiley +1 more source
BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study
Fulvio Braido,1,2 Enrico Arnaboldi,1,2 Sara Barile,3 Luca Cavalieri,4 Eleonora Ingrassia,4 Maria Russo,1,2 Alessio Piraino4 1Respiratory Unit for Continuity of Care, IRCCS, Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medicine
Braido F +6 more
doaj
81-83A new UV spectrophotometric method for the simultaneous determination of formoterol fumarate and budesonide in their combined dosage form has been developed.
Prasad, A V S S
core
The electrochemical oxidation of formoterol fumarate (formoterol) has been carried out in aqueous solution in the pH range of 1.5-10.0 by cyclic, linear sweep, differential-pulse and square-wave voltammetry.
Demircigil, B. T. +3 more
core +1 more source
Chronic obstructive pulmonary disease (COPD) is a condition characterised by poorly reversible airflow limitation that is generally progressive and causes serious disability.
Sakinatus Syarifah, Muhammad Amin
doaj +1 more source
Development and validation of RP-HPLC method for Simultaneous Estimation of Formoterol Fumarate and Budesonide in their Combined Dosage Form [PDF]
AIM & OBJECTIVES: There is several basic criteria for new method development of drug molecules. For example a) The drug or drug combination may not be official in any pharmacopoeias b) A proper analytical procedure for the drug may not be available in ...
Kumar, A
core
Masakazu Ichinose,1 Yasushi Fukushima,2 Yoshikazu Inoue,3 Osamu Hataji,4 Gary T Ferguson,5 Klaus F Rabe,6 Nobuya Hayashi,7 Hiroshi Okada,7 Mami Takikawa,7 Eric Bourne,8 Shaila Ballal,9 Kiernan DeAngelis,10 Magnus Aurivillius,11 Paul Dorinsky,8 Colin ...
Ichinose M +14 more
doaj
Assessment of drug permeability using a small airway microphysiological system
BackgroundThere is a need to reliably predict the permeability of inhaled compounds during the development of new and generic drugs. A small airway microphysiological system (MPS) that can recapitulate the pulmonary air-liquid interface (ALI) with ...
Robert M. Geiger +18 more
doaj +1 more source
Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia
Our study probed the effects of the beta-2 adrenergic agonist, formoterol and the macrolide antibiotic, roxithromycin, on muscle wasting in a well-characterized animal model of cancer cachexia. Female Wistar rats were inoculated with Yoshida AH130 ascites hepatoma (AH) cells to induce rapid and severe cachexia as demonstrated by wet weight ...
Richard A, Kenley +4 more
openaire +3 more sources

